Your browser doesn't support javascript.
loading
Empagliflozin containing chitosan-alginate nanoparticles in orodispersible film: preparation, characterization, pharmacokinetic evaluation and its in-vitro anticancer activity.
Sinha, Suhani; Garg, Vandana; Thapa, Sonia; Singh, Shashank; Chauhan, Mahima; Dutt, Rohit; Singh, Rahul Pratap.
Afiliação
  • Sinha S; Department of Pharmacy, School of Medical and Allied Sciences, G. D. Goenka University, Gurugram, Haryana, India.
  • Sonali; Guru Teg Bahadur Hospital, GTB Enclave, Dilshad Garden, New Delhi, Delhi, India.
  • Garg V; Department of Pharmaceutical Sciences, Maharshi Dayanand University, Rohtak, Haryana, India.
  • Thapa S; Academy of Scientific and Innovative Research, CSIR-Indian Institute of Integrative Medicine, Jammu, Jammu and Kashmir, India.
  • Singh S; Academy of Scientific and Innovative Research, CSIR-Indian Institute of Integrative Medicine, Jammu, Jammu and Kashmir, India.
  • Chauhan M; Department of Pharmacy, School of Medical and Allied Sciences, G. D. Goenka University, Gurugram, Haryana, India.
  • Dutt R; Department of Pharmacy, School of Medical and Allied Sciences, G. D. Goenka University, Gurugram, Haryana, India.
  • Singh RP; Department of Pharmacy, School of Medical and Allied Sciences, G. D. Goenka University, Gurugram, Haryana, India.
Drug Dev Ind Pharm ; 48(7): 279-291, 2022 Jul.
Article em En | MEDLINE | ID: mdl-35913103
ABSTRACT

OBJECTIVE:

The main objective of this study was to develop the orodispersity film containing chitosan-alginate nanoparticles to improve dissolution profile, therapeutic effect with improved bioavailability of empagliflozin through oral route noninvasively for further cytotoxicity study.

METHODS:

The nanoparticles were developed through two-step mechanisms ionotropic pre-gelation and polyelectrolyte complexation methods. The prepared nanoparticles were added to a polymer matrix containing hypromellose, polyvinyl alcohol, and maltodextrin and cast to rapidly dissolving thin film by solvent casting method.

RESULTS:

The physicochemical characteristics of empagliflozin in the orodispersible film were most favorable for further studies. This formulation has achieved a higher permeability (7.2-fold) as compared to the reference drug product (Jardiance) after 45 min. In vivo pharmacokinetic studies in Wistar rats have revealed that chitosan-alginate empagliflozin nanoparticles in the orodispersible film were 1.18-fold more bioavailable in comparison to free empagliflozin in orodispersible film. The Cmax observed for the empagliflozin-loaded orodispersible film was 15.42 ± 5.13 µg/mL in comparison to 18.21 ± 5.53 µg/mL for empagliflozin nanoparticle-containing orodispersible film and 12.19 ± 6.71 µg/mL for freed rug suspension. The t1/2and AUC0-t values for chitosan-alginate nanoparticles of empagliflozin in the orodispersible film were found1.4-fold more than empagliflozin loaded orodispersible film (without nanoparticles). The cytotoxicity study has shown that chitosan-alginate nanoparticles of empagliflozin in orodispersible film achieved a 2.5-fold higher cytotoxic effect than free empagliflozin in orodispersible film in A549lung cancer cells.

CONCLUSIONS:

This study provides evidence that chitosan-alginate nanoparticles of empagliflozin in orodispersible film can be an effective drug carrier system to improve sustained effect with better bioavailability of poorly water-soluble drug.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Quitosana / Nanopartículas Limite: Animals Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Quitosana / Nanopartículas Limite: Animals Idioma: En Ano de publicação: 2022 Tipo de documento: Article